T-MAXIMUM Pharmaceutical Inc: Clinical Trials

2 trials sponsored by T-MAXIMUM Pharmaceutical Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 2

Follow T-MAXIMUM Pharmaceutical Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The METAMAX Study: MT027 Allogeneic CAR-T for Brain Metastases From Advanced Solid Tumors
Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3 - Brain Metastases From Solid Tumors
Phase 2Not yet recruitingT-MAXIMUM Pharmaceutical Inc402027-12-302026-10-27
The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3 - Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Phase 2Not yet recruitingT-MAXIMUM Pharmaceutical Inc402026-11-302026-10-14

Conditions studied

Recurrence (1)

Countries

Taiwan (2)  ·  United States (2)